High Net Worth Advisory Group LLC Arcellx, Inc. Transaction History
High Net Worth Advisory Group LLC
- $358 Million
- Q3 2024
A detailed history of High Net Worth Advisory Group LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 8,500 shares of ACLX stock, worth $642,090. This represents 0.2% of its overall portfolio holdings.
Number of Shares
8,500
Previous 8,000
6.25%
Holding current value
$642,090
Previous $441,000
60.77%
% of portfolio
0.2%
Previous 0.13%
Shares
7 transactions
Others Institutions Holding ACLX
# of Institutions
204Shares Held
44.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$302 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$294 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$283 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$266 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$186 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.31B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...